Rebel Medicine
PrivateLast Round
Series A
Jun 12, 2025
Total Funding Raised
$11.16M
Momentum Score
50 /100
Company Overview
Rebel Medicine is a biotechnology company that develops non-opioid solutions for acute and post-operative pain management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rebel Medicine Comps
Public and private peers based on sector, stage, and business model.
Rebel Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 12, 2025 | ||||
| Seed | Feb 6, 2025 | ||||
| Grant | Sep 1, 2020 |
Key People
Founding team and executive leadership
Rebel Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| Central Texas Angel Network | Series A, Seed |
| Crocker Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 170% MoM.
Rebel Medicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rebel Medicine's valuation, stock price, and market status.
